TempTraq showcases new 48-hour body temperature monitor
CLEVELAND — Blue Spark Technologies last week at CES showcased TempTraq’s new 48-hour body temperature monitor, doubling the run-time of its existing patch. To help parents care for sick children, especially through the night, the TempTraq wearable, Bluetooth temperature monitor continuously senses, records and sends body temperature for up to 48 hours to a mobile device through its free downloadable app.
TempTraq alleviates many concerns of those caring for a sick child, including eliminating the need to continually disturb or wake them when rest is critical to a speedy recovery. Plus, no more poking or prodding an already irritable child to get an accurate temperature reading. The wearable patch delivers on-the-spot temperature readings in just seconds and even sends alerts to mobile devices when the child reaches a pre-determined, user-set temperature level.
Unlike other devices that provide users with only one point of data and offer no continuous monitoring or alerts, the accompanying free downloadable TempTraq app allows users of all ages to reach a new level of health care. It displays both real-time and historical temperature data transmitted from the patch in graphical or tabular views, making it possible for caregivers to see fluctuations and quickly adapt treatment, if necessary.
TempTraq further simplifies the temperature reading process by providing easy-to-follow colors that indicate temperature levels: Green, less than 100.4°F; orange, equal to or greater than 100.4°F; red, equal to or above the user-set temperature alert level.
For those who want to share temperature data with their doctors or family members, TempTraq allows users to securely send temperature information via email. Through the app, users can also keep track of when the patient eats, drinks or takes medicine. For those caring for multiple people, the TempTraq app conveniently allows them to monitor multiple patches simultaneously.
TempTraq’s existing 24-hour patch is available now for $19.99 online at Amazon.com, Target.com, and CVS.com and in stores at Walgreens, CVS, Target, Kroger, Fry’s, Dillon’s, Ralph’s and Hy-Vee.
The new 48-hour patch will be available for purchase for $24.99 in Q1 2017.
CRN joins IPA on industry guidelines for marketing probiotics
WASHINGTON — The Council for Responsible Nutrition and the International Probiotics Association on Monday issued scientifically-based best-practice guidelines for the labeling, storing, and stability testing of dietary supplements and functional foods containing probiotics. As probiotics are quickly gaining popularity, the guidelines are designed to ensure probiotic manufacturers can consistently create high-quality products in which consumers can be confident.
“We trust the industry will embrace these guidelines and integrate them into their labeling and manufacturing practices,” stated Andrea Wong, VP scientific and regulatory affairs, CRN. “As more and more consumers incorporate probiotic products into their daily health regimen, we felt it was essential to develop a roadmap for companies producing and marketing these products to ensure that they meet consistent, high-quality standards.”
“We believe these guidelines will raise the bar for the probiotic industry,” added George Paraskevakos, executive director, IPA. “In working with CRN to develop this critical list of recommendations, we’ve demonstrated that the dietary supplement and functional food industry is proactive and responsible when it comes to meaningful self-regulation," he said. "These guidelines reflect the most up-to-date science and industry thinking, and will continue to be updated as best practices evolve.”
Stressing the importance of providing meaningful information to consumers, the guidelines recommend that the quantitative amount of probiotics in a product should be expressed in colony forming units (CFUs). “CFU is the scientifically accepted unit of measure for probiotics. Labeling probiotic products in CFUs gives consumers the best information possible when it comes to the viable microorganisms present in the product throughout shelf life,” Wong said.
Additionally, the guidelines’ stability testing recommendations are designed to ensure that the stated shelf life of a given probiotic product is scientifically-supported. Storage and handling recommendations advise manufacturers to consider individual product formulations and packaging, as well as storage and transport environments.
Omron unveils tech breakthroughs in BPM at CES
LAS VEGAS — Omron Healthcare last week unveiled its next generation prototype, Project Zero 2.0 – an ultra-compact, wearable wrist device that measures blood pressure with clinical accuracy and tracks other heart health data such as sleep patterns – at the CES Digital Health Summit here. The company also showcased the Omron EVOLV upper arm blood pressure monitor – which has just launched for retail purchase – and the HeartVue wrist monitor which stole the spotlight when it was previewed at the CES Digital Health Summit in 2016 and is expected to arrive in stores this spring.
"Omron continues to evolve the experience of checking your blood pressure with technology that is increasingly more portable, more mobile, more connected and easier to use," stated Ranndy Kellogg, Omron president and CEO. "Checking your blood pressure only in a doctor's office or in a machine at a pharmacy has been redefined by convenient clinically-accurate Omron personal medical devices that can be used at home, at work or on the go," he said. "We are revolutionizing personal heart health technology to encourage behavior that we know can save lives."
Omron previewed its next generation of in-development Omron blood pressure monitors, a prototype of the Project Zero 2.0 wrist monitor. The prototype is a "wearable" medical device that measures blood pressure with clinical accuracy at the push of a button.
Project Zero 2.0 has the appearance of a wristwatch and, in addition to blood pressure, will measure physical activity and sleep. The device marks the first time that such technology has been miniaturized sufficiently to accurately measure blood pressure and to fit in the form of a watch.
Like all Omron connected devices, the Project Zero 2.0 wrist monitor will sync with an Omron app, so users can track and share vital data with their healthcare providers. The device features a rechargeable battery and will last about a week on one charge.
"The Project 2.0 technology will redefine what have become standard notions of 'wearable'," Kellogg said. "Our devices are a necessity, not a novelty. Omron blood pressure monitors are medical devices that measure far more than steps or heart rate; they provide accurate insights into your blood pressure numbers."
Meanwhile, the Omron EVOLV was previewed at CES 2016 as an Omron Project Zero prototype upper arm device. The company just released the EVOLV for retail sale on OmronHealthcare.com, and it will become widely available in retail pharmacies in the coming weeks. The EVOLV is a one-piece monitor that has no tabletop unit, no tubes and no wires. Users place the entire unit on the upper arm and the blood pressure reading is displayed in bold numbers right on the face of the device. The monitor uses Omron Healthcare's exclusive heart health algorithm, Advanced Accuracy, to measure more data points and eliminate movements to get the most precise reading. The EVOLV syncs with the OMRON Connect US App via Bluetooth® so readings can be stored, tracked over time and shared.
In additiion, Omron feartured its Omron HeartVue, the smallest monitor Omron has ever made to date that will be released for sale this spring. This discreet, ultra-portable device is free of upper arm cuffs, wires or hoses and can be custom fit to the user's wrist.
In addition to blood pressure measurement, HeartVue also tracks physical activity and provides sleep data. HeartVue works seamlessly with the Omron Connect US App so readings can be shared with a doctor for more insightful care.
Along with the new devices, Omron introduced its newest app, which syncs with the new EVOLV and the HeartVue. The OMRON Connect US App provides a complete view of blood pressure with systolic, diastolic and pulse readings and maintains data on BMI, body fat percentage and weight all in one place so users can track progress over time. An easy to navigate, approachable, non-intimidating interface features an intuitive dashboard that conveniently charts and graphs data – all customizable by day, week, month or year. Users may quickly and conveniently email readings to a doctor or family member anywhere, anytime. Users of the new EVOLV and HeartVue devices can download the new OMRON Connect US App for free from the Apple iOS or Google Play stores.
Omron Healthcare recently announced an evolution in its goal – Going for Zero heart attacks and strokes – and these technological strides represent the company's investment in that mission.
"We have made Going for Zero – the elimination of heart attack and stroke – the guiding principle for everything we do, including the innovation we're showing at CES," said Kellogg. "Creating technology that encourages regular monitoring and improves communication and quality of care is a core piece of that broader national effort."